INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 43 filers reported holding INMUNE BIO INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $283,325 | -40.3% | 41,850 | -19.9% | 0.00% | – |
Q2 2023 | $474,430 | +36.9% | 52,250 | -2.6% | 0.00% | – |
Q1 2023 | $346,540 | +21.4% | 53,644 | +19.1% | 0.00% | – |
Q4 2022 | $285,490 | +15.1% | 45,030 | +12.7% | 0.00% | – |
Q3 2022 | $248,000 | -27.9% | 39,950 | +2.6% | 0.00% | – |
Q2 2022 | $344,000 | +13.5% | 38,950 | +8.3% | 0.00% | – |
Q1 2022 | $303,000 | -17.4% | 35,950 | 0.0% | 0.00% | – |
Q4 2021 | $367,000 | -37.3% | 35,950 | +19.3% | 0.00% | – |
Q3 2021 | $585,000 | +346.6% | 30,126 | +304.6% | 0.00% | – |
Q2 2021 | $131,000 | +235.9% | 7,446 | +125.0% | 0.00% | – |
Q1 2021 | $39,000 | +875.0% | 3,309 | +1223.6% | 0.00% | – |
Q4 2020 | $4,000 | 0.0% | 250 | -69.5% | 0.00% | – |
Q2 2020 | $4,000 | 0.0% | 820 | -27.4% | 0.00% | – |
Q1 2020 | $4,000 | – | 1,129 | +2158.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 50 | -92.7% | 0.00% | – |
Q3 2019 | $4,000 | +100.0% | 686 | +139.0% | 0.00% | – |
Q2 2019 | $2,000 | -77.8% | 287 | -76.3% | 0.00% | – |
Q1 2019 | $9,000 | – | 1,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 178,284 | $1,219,463 | 0.13% |
Fermata Advisors, LLC | 56,702 | $383,888 | 0.11% |
Westside Investment Management, Inc. | 41,540 | $281,227 | 0.08% |
QUADRANT CAPITAL GROUP LLC | 60,000 | $406,200 | 0.04% |
MAI Capital Management | 97,410 | $659,466 | 0.01% |
Janney Montgomery Scott LLC | 256,887 | $1,739 | 0.01% |
Financial Advocates Investment Management | 11,510 | $78,320 | 0.01% |
VALLEY NATIONAL ADVISERS INC | 1,000 | $7 | 0.00% |
Beacon Pointe Advisors, LLC | 10,368 | $70,191 | 0.00% |
Asset Dedication, LLC | 814 | $6 | 0.00% |